Drug application
LEVOLEUCOVORIN CALCIUM (LEVOLEUCOVORIN CALCIUM)
Drugs@FDA ANDA 213797 · QUAGEN
Key facts
| Drug name | LEVOLEUCOVORIN CALCIUM |
|---|---|
| Active ingredients | LEVOLEUCOVORIN CALCIUM |
| Application type | ANDA |
| Application number | 213797 |
| Company | QUAGEN |
| Dosage forms | SOLUTION, INTRAVENOUS |
| Strength | EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Nov 2, 2021 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.